These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34445179)

  • 1. Kidney Response to Chemotherapy-Induced Heart Failure: mRNA Analysis in Normotensive and
    Jíchová Š; Gawryś O; Kompanowska-Jezierska E; Sadowski J; Melenovský V; Hošková L; Červenka L; Kala P; Veselka J; Čertíková Chábová V
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasodilatory responses of renal interlobular arteries to epoxyeicosatrienoic acids analog are not enhanced in Ren-2 transgenic hypertensive rats: evidence against a role of direct vascular effects of epoxyeicosatrienoic acids in progression of experimental heart failure.
    Sporková A; Husková Z; Škaroupková P; Rami Reddy N; Falck JR; Sadowski J; Červenka L
    Physiol Res; 2017 Mar; 66(1):29-39. PubMed ID: 27782740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined suppression of the intrarenal and circulating vasoconstrictor renin-ACE-ANG II axis and augmentation of the vasodilator ACE2-ANG 1-7-Mas axis attenuates the systemic hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
    Červenka L; Bíbová J; Husková Z; Vaňourková Z; Kramer HJ; Herget J; Jíchová Š; Sadowski J; Hampl V
    Physiol Res; 2015; 64(1):11-24. PubMed ID: 25194129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deleterious Effects of Hyperactivity of the Renin-Angiotensin System and Hypertension on the Course of Chemotherapy-Induced Heart Failure after Doxorubicin Administration: A Study in Ren-2 Transgenic Rat.
    Kala P; Bartušková H; Piťha J; Vaňourková Z; Kikerlová S; Jíchová Š; Melenovský V; Hošková L; Veselka J; Kompanowska-Jezierska E; Sadowski J; Gawrys O; Maxová H; Červenka L
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma and kidney angiotensin II levels and renal functional responses to AT(1) receptor blockade in hypertensive Ren-2 transgenic rats.
    Kopkan L; Kramer HJ; Husková Z; Vanourková Z; Bäcker A; Bader M; Ganten D; Cervenka L
    J Hypertens; 2004 Apr; 22(4):819-25. PubMed ID: 15126925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of nNOS in regulation of renal function in hypertensive Ren-2 transgenic rats.
    Cervenka L; Kramer HJ; Malý J; Vanecková I; Bäcker A; Bokemeyer D; Bader M; Ganten D; Mitchell KD
    Physiol Res; 2002; 51(6):571-80. PubMed ID: 12511180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic endothelin receptor blockade reduces end-organ damage independently of blood pressure effects in salt-loaded heterozygous Ren-2 transgenic rats.
    Opocenský M; Dvorák P; Malý J; Kramer HJ; Bäcker A; Kopkan L; Vernerová Z; Tesar V; Zima T; Bader M; Ganten D; Janda J; Vanecková I
    Physiol Res; 2004; 53(6):581-93. PubMed ID: 15588125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
    Červenka L; Melenovský V; Husková Z; Škaroupková P; Nishiyama A; Sadowski J
    Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):795-807. PubMed ID: 25969338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proximal tubular fluid, kidney, and plasma levels of angiotensin II in hypertensive ren-2 transgenic rats.
    Mitchell KD; Jacinto SM; Mullins JJ
    Am J Physiol; 1997 Aug; 273(2 Pt 2):F246-53. PubMed ID: 9277585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of anesthesia on plasma and kidney ANG II levels in normotensive and ANG II-dependent hypertensive rats.
    Husková Z; Kramer HJ; Thumová M; Vanourková Z; Bürgelová M; Teplan V; Malý J; Cervenka L
    Kidney Blood Press Res; 2006; 29(2):74-83. PubMed ID: 16651849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats.
    Jacinto SM; Mullins JJ; Mitchell KD
    Am J Physiol; 1999 Feb; 276(2):F315-22. PubMed ID: 9950963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of cyclooxygenase-2 inhibition on renal function in heterozygous ren-2-transgenic rats on normal or low sodium intake.
    Vanecková I; Cahová M; Kramer HJ; Husková Z; Skaroupková P; Komers R; Bader M; Ganten D; Cervenka L
    Kidney Blood Press Res; 2004; 27(4):203-10. PubMed ID: 15273422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of changes in sodium balance on plasma and kidney angiotensin II levels in anesthetized and conscious Ren-2 transgenic rats.
    Husková Z; Kramer HJ; Vanourková Z; Cervenka L
    J Hypertens; 2006 Mar; 24(3):517-27. PubMed ID: 16467655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Sympathetic Denervation Attenuates Congestive Heart Failure in Angiotensin II-Dependent Hypertension: Studies with Ren-2 Transgenic Hypertensive Rats with Aortocaval Fistula.
    Honetschlagerová Z; Gawrys O; Jíchová Š; Škaroupková P; Kikerlová S; Vaňourková Z; Husková Z; Melenovský V; Kompanowska-Jezierska E; Sadowski J; Kolář F; Novotný J; Hejnová L; Kujal P; Červenka L
    Kidney Blood Press Res; 2021; 46(1):95-113. PubMed ID: 33530085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system.
    Varcabova S; Huskova Z; Kramer HJ; Hwang SH; Hammock BD; Imig JD; Kitada K; Cervenka L
    Clin Exp Pharmacol Physiol; 2013 Apr; 40(4):273-81. PubMed ID: 23039246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of AT1 and AT2 receptors in the hypertensive Ren-2 gene transgenic rat kidney.
    Zhuo J; Ohishi M; Mendelsohn FA
    Hypertension; 1999 Jan; 33(1 Pt 2):347-53. PubMed ID: 9931128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
    Hampl V; Herget J; Bíbová J; Baňasová A; Husková Z; Vaňourková Z; Jíchová Š; Kujal P; Vernerová Z; Sadowski J; Červenka L
    Physiol Res; 2015; 64(1):25-38. PubMed ID: 25194138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?
    Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L
    Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of ET(A) receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats.
    Čertíková Chábová V; Vernerová Z; Kujal P; Husková Z; Škaroupková P; Tesař V; Kramer HJ; Kompanowska-Jezierska E; Walkowska A; Sadowski J; Červenka L; Vaněčková I
    Life Sci; 2014 Nov; 118(2):297-305. PubMed ID: 24373834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
    Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.